Abstract
Background: The anti-tumour antibiotic mithramycin is also a potent inhibitor of fibrosis after glaucoma surgery. This drug displays high affinity binding to GC-rich sequences in DNA, including those present in the promoter of the gene encoding the α1 chain of type I collagen (COL1A1).
Objective: To evaluate the effects of mithramycin on COL1A1 expression in systemic sclerosis fibroblasts.
Methods: Confluent cultures of dermal fibroblasts from patients with recent onset diffuse systemic sclerosis were treated with mithramycin in vitro. Cell viability and protein expression were examined by fluorescence and confocal imaging. Type I collagen production was analysed by confocal imaging and metabolic labelling. COL1A1 messenger RNA levels and stability were assessed by northern hybridisation, and COL1A1 transcription was examined by transient transfections.
Results: Treatment of systemic sclerosis fibroblasts with mithramycin (10–100 nmol/l) did not cause significant cytotoxicity. Type I collagen biosynthesis decreased by 33–40% and 50–70% in cells cultured with mithramycin at 10 nmol/l and 100 nmol/l, respectively. Mithramycin at 50 nmol/l decreased COL1A1 mRNA levels by 40–60%. The effects of mithramycin on collagen gene expression were mediated by transcriptional and post-transcriptional mechanisms as shown by the reduction of COL1A1 promoter activity and by a decrease in the stability of these transcripts, respectively.
Conclusions: Mithramycin causes potent inhibition of collagen production and gene expression in systemic sclerosis dermal fibroblasts in vitro in the absence of cytotoxic effects. These results suggest that this drug may be an effective treatment for the fibrotic process which is the hallmark of systemic sclerosis.
Full Text
The Full Text of this article is available as a PDF (351.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Campbell V. W., Davin D., Thomas S., Jones D., Roesel J., Tran-Patterson R., Mayfield C. A., Rodu B., Miller D. M., Hiramoto R. A. The G-C specific DNA binding drug, mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liver. Am J Med Sci. 1994 Mar;307(3):167–172. doi: 10.1097/00000441-199403000-00002. [DOI] [PubMed] [Google Scholar]
- Chen S. J., Chen Y. F., Miller D. M., Li H., Oparil S. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo. Circulation. 1994 Nov;90(5):2468–2473. doi: 10.1161/01.cir.90.5.2468. [DOI] [PubMed] [Google Scholar]
- Chiang S. Y., Azizkhan J. C., Beerman T. A. A comparison of DNA-binding drugs as inhibitors of E2F1- and Sp1-DNA complexes and associated gene expression. Biochemistry. 1998 Mar 3;37(9):3109–3115. doi: 10.1021/bi9721142. [DOI] [PubMed] [Google Scholar]
- Diaz A., Jiménez S. A. Interferon-gamma regulates collagen and fibronectin gene expression by transcriptional and post-transcriptional mechanisms. Int J Biochem Cell Biol. 1997 Jan;29(1):251–260. doi: 10.1016/s1357-2725(96)00112-4. [DOI] [PubMed] [Google Scholar]
- Eckes B., Mauch C., Hüppe G., Krieg T. Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J. 1996 Apr 15;315(Pt 2):549–554. doi: 10.1042/bj3150549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaidarova Svetlana, Jiménez Sergio A. Inhibition of basal and transforming growth factor-beta-induced stimulation of COL1A1 transcription by the DNA intercalators, mitoxantrone and WP631, in cultured human dermal fibroblasts. J Biol Chem. 2002 Jul 23;277(41):38737–38745. doi: 10.1074/jbc.M201742200. [DOI] [PubMed] [Google Scholar]
- Hardenbol P., Van Dyke M. W. In vitro inhibition of c-myc transcription by mithramycin. Biochem Biophys Res Commun. 1992 Jun 15;185(2):553–558. doi: 10.1016/0006-291x(92)91660-i. [DOI] [PubMed] [Google Scholar]
- Hitraya E. G., Jiménez S. A. Transcriptional activation of the alpha 1(I) procollagen gene in systemic sclerosis dermal fibroblasts. Role of intronic sequences. Arthritis Rheum. 1996 Aug;39(8):1347–1354. doi: 10.1002/art.1780390812. [DOI] [PubMed] [Google Scholar]
- Hitraya E. G., Varga J., Artlett C. M., Jiménez S. A. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis. Arthritis Rheum. 1998 Nov;41(11):2048–2058. doi: 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
- Hämäläinen L., Oikarinen J., Kivirikko K. I. Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol. J Biol Chem. 1985 Jan 25;260(2):720–725. [PubMed] [Google Scholar]
- Ihn H., Tamaki K. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene. Arthritis Rheum. 2000 Oct;43(10):2240–2247. doi: 10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
- Jackson S. P., Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell. 1988 Oct 7;55(1):125–133. doi: 10.1016/0092-8674(88)90015-3. [DOI] [PubMed] [Google Scholar]
- Jimenez S. A., Saitta B. Alterations in the regulation of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol. 1999;21(4):397–414. doi: 10.1007/BF00870302. [DOI] [PubMed] [Google Scholar]
- Jimenez S. A., Varga J., Olsen A., Li L., Diaz A., Herhal J., Koch J. Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1. J Biol Chem. 1994 Apr 29;269(17):12684–12691. [PubMed] [Google Scholar]
- Jimenez Sergio A., Derk Chris T. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med. 2004 Jan 6;140(1):37–50. [PubMed] [Google Scholar]
- Nehls M. C., Brenner D. A., Gruss H. J., Dierbach H., Mertelsmann R., Herrmann F. Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast. J Clin Invest. 1993 Dec;92(6):2916–2921. doi: 10.1172/JCI116914. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Ray R., Snyder R. C., Thomas S., Koller C. A., Miller D. M. Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest. 1989 Jun;83(6):2003–2007. doi: 10.1172/JCI114110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szalai G., Krishnamurthy R., Hajnóczky G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J. 1999 Nov 15;18(22):6349–6361. doi: 10.1093/emboj/18.22.6349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vigneswaran N., Mayfield C. A., Rodu B., James R., Kim H. G., Miller D. M. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter. Biochemistry. 1996 Jan 30;35(4):1106–1114. doi: 10.1021/bi951562b. [DOI] [PubMed] [Google Scholar]